Active Ingredient(s): Mercaptopurine, 6-MP
FDA Approved: * September 11, 1953
Pharm Company: * TEVA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Purinethol Overview

Mercaptopurine (6-MP), sold under the brand name Purinethol, is an immunosuppressive medication. It is used to treat acute lymphocytic leukemia, Crohn's disease, and ulcerative colitis.[1] It is a thiopurine.[2] It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.[3] Contents 1 Medical uses 2 Side effects 2.1 Precautions 3 Drug interactions 4 Mechanisms of action 4.1 Pharmacogenetics 5 History 6 See also 7 References ...

Read more Purinethol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mercaptopurine

Recent Purinethol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mercaptopurine, 6-MP
  • Suspension: 20mg/ml
  • Tablet: 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Purinethol: (1 result)

Sorted by National Drug Code
  • 57844-522 Purinethol 50 mg Oral Tablet by Gate Pharmaceuticals

Other drugs which contain Mercaptopurine, 6-MP or a similar ingredient: (3 results)